16KIT
A GOOD GAME OF ONEUPMANSHIP
A trio of new - or improved - glucose sensors are
about to become available in the UK.
ABBOTT "Since we launched the first disposable glucose
sensor in 2014, we've always believed all people with
diabetes should have access to high-quality, accurate and
affordable diabetes technologies," adds Watkin. "That's
why Abbott disrupted the traditional notion that CGMs
have to sacrifice quality or accuracy for affordability,
and we built our FreeStyle Libre family of products to
deliver unparalleled results at a lower cost than any other
CGM available."
Next generation
The FreeStyle Libre 3 system includes the FreeStyle Libre
3 mobile app which is designed to enable users to capture
and view their real-time glucose levels, glucose history
and trend arrows showing how their glucose is changing
with just a glance at their smartphone.
Abbott designed its next-generation FreeStyle Libre 3
system to be more sustainable for the environment with
a smaller and more discreet sensor, reducing the total
volume by more than 70%. With a 41% reduction in plastic
use and 43% reduction in carton paper, the new sensor
design aligns with the company's continued commitment
to sustainability.
Abbott is a global healthcare leader that helps people
live more fully at all stages of life. Its portfolio of lifechanging
technologies spans the spectrum of healthcare,
with leading businesses and products in diagnostics,
medical devices, nutritionals and branded generic
medicines. Its 107,000 colleagues serve people in more
than 160 countries.
DEXCOM
Dexcom, fresh from celebrating gaining a CE Mark for
its G7 sensor, has also announced another new product,
Dexcom ONE. This is expected to be on prescription via
the NHS England in the coming months, demonstrating
a huge step forward in access to diabetes technology
and improved access to potentially lifesaving technology
for people with diabetes. This product is an affordable,
accessible and easy-to-use rt-CGM that will enable
more people with diabetes to gain greater control over
their condition.
Recently Abbott announced it had secured CE Mark
(Conformité Européenne) for its next-generation
FreeStyle Libre 3 system. The FreeStyle Libre 3
technology provides continuous, real-time glucose
readings automatically delivered to smartphones every
minute, offering unsurpassed 14-day accuracy1 in the
smallest and thinnest sensor design at the same price as
previous versions of the device.
"Abbott won't stop innovating when there's room to
raise the bar. We've done that again with FreeStyle Libre
3, the smallest sensor that delivers life-changing benefits
and best-in-class accuracy," says Jared Watkin, senior
vice president, Diabetes Care, Abbott. "People living with
diabetes are at the centre of our design process, and we
made our next-generation technology even more discreet
for a better user experience to make managing diabetes
as easy and seamless as possible."
With a 14-day wear time, the FreeStyle Libre 3 is
easy to apply with a one-piece applicator. It is worn
on the back of the upper arm, eliminating the need for
painful fingersticks to view glucose levels. To allow as
many people as possible living with diabetes to access
and benefit from the significant advancements of the
technology, Abbott's FreeStyle Libre 3 system will be
priced the same as previous generations of the device.
FSL 3 size of two stacked American dimes.